Post-approval studies (Phase 4)Looking for participantsNCT05206331
What this trial is testing
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
Who this might be right for
Breast Cancer
Margarita Louise Zuley 2,100